Authorization Under Uncertainty

Authorization Under Uncertainty is a regulatory decision-making framework that permits the provisional approval of medical products based on preliminary evidence, pending the verification of clinical benefit through post-marketing studies.

10

Publications

281

Citations

58

Authors

42

Institutions

Publications per year

2017–2026

7

Authors

58

  1. JH
    Jarno Hoekman

    Utrecht University, Netherlands

    2 publications · 40 citations

    2

    h-index

  2. MH
    Mickaël Hiligsmann

    Maastricht University, Netherlands

    1 publications · 13 citations

    1

    h-index

  3. MG
    Mònica Gómez-Valent

    University Hospital Heidelberg, Germany

    1 publications · 67 citations

    1

    h-index

  4. UE
    Un. Ece. Secretariat

    1 publications · 52 citations

    1

    h-index

  5. JT
    Josep Torrent-Farnell

    Universitat Autònoma de Barcelona, Spain

    1 publications · 67 citations

    1

    h-index

1–5 of 58

Venues

  1. 2

    h-index

  2. Social Science & Medicine

    1 publications · 23 citations

    1

    h-index

  3. Health Policy and Technology

    1 publications · 13 citations

    1

    h-index

  4. Clinical Pharmacology & Therapeutics

    CPT · 1 publications · 17 citations

    1

    h-index

  5. PharmacoEconomics

    1 publications · 47 citations

    1

    h-index

1–5